TwinEdge Bioscience
TwinEdge Bioscience is a techbio company focused on developing digital avatars, also known as digital twins, for oncology drug discovery and development. Their proprietary methodology combines computational biology, artificial intelligence, and personalized medicine to create actionable digital representations of patient tumors, enabling "in-avatar" trials. TwinEdge is building the world's largest population of digital twins, aiming to provide population-scale insights to pharmaceutical and biotechnology clients to improve decision-making in drug development. They serve clients across Europe, North America, and Asia, as well as principal investigators, academia, and patient foundations. The company recently launched its collection of over 10,000 patient avatars.
TwinEdge Bioscience
TwinEdge Bioscience is a techbio company focused on developing digital avatars, also known as digital twins, for oncology drug discovery and development. Their proprietary methodology combines computational biology, artificial intelligence, and personalized medicine to create actionable digital representations of patient tumors, enabling "in-avatar" trials. TwinEdge is building the world's largest population of digital twins, aiming to provide population-scale insights to pharmaceutical and biotechnology clients to improve decision-making in drug development. They serve clients across Europe, North America, and Asia, as well as principal investigators, academia, and patient foundations. The company recently launched its collection of over 10,000 patient avatars.